| 1 |
equivalent dose in 2-Gy fractions
(189 times)
|
Neoplasms
(119 times)
|
OS (33 times)
RT (29 times)
EBRT (23 times)
|
2003 Defining the optimal dose of radiation after incomplete resection of central neurocytomas.
|
| 2 |
equivalent dose in 2 Gy
(34 times)
|
Neoplasms
(18 times)
|
HR-CTV (5 times)
RT (5 times)
CT (4 times)
|
2009 Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
|
| 3 |
equivalent 2 Gy dose
(7 times)
|
Neoplasms
(2 times)
|
CTV (2 times)
IMRT (2 times)
SBRT (2 times)
|
2014 Primary peritoneal clear cell carcinoma treated with IMRT and interstitial HDR brachytherapy: a case report.
|
| 4 |
equieffective dose at 2 Gy
(3 times)
|
Brachytherapy
(1 time)
|
PTV (2 times)
dose to ml (1 time)
EBRT (1 time)
|
2016 Simultaneous integrated protection : Anew concept for high-precision radiation therapy.
|
| 5 |
equivalent dose when delivered in 2Gy/fraction
(3 times)
|
Neoplasms
(2 times)
|
BIS (1 time)
CMR (1 time)
CP (1 time)
|
2014 A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC).
|
| 6 |
Equivalent 2Gy fraction doses
(2 times)
|
Neoplasms
(1 time)
|
AVMs (1 time)
CO (1 time)
HSRT (1 time)
|
2016 Predictors for occlusion of cerebral AVMs following radiation therapy : Radiation dose and prior embolization, but not Spetzler-Martin grade.
|
| 7 |
equivalent dose at fractionation of 2Gy
(2 times)
|
Neoplasms
(2 times)
|
CI (1 time)
HR (1 time)
|
2014 Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer.
|
| 8 |
2Gy-equivalent dose
(1 time)
|
|
PSS (1 time)
RT (1 time)
|
2022 Incidence and predictors of toxicity in the management of vulvar squamous cell carcinoma treated with radiation therapy.
|
| 9 |
equivalent 2-Gy dose maximum
(1 time)
|
|
1-7mm (1 time)
SBRT (1 time)
|
2015 Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy.
|
| 10 |
equivalent conventional total dose of 2 Gy/fraction
(1 time)
|
Breast Diseases
(1 time)
|
CRT (1 time)
hRT (1 time)
LDM (1 time)
|
2021 Were We Able to Reduce Cardiac Doses in Breast Cancer Radiotherapy Over Time?
|
| 11 |
equivalent dose according to 2 Gy
(1 time)
|
Brachytherapy
(1 time)
|
HR-CTV (1 time)
T-ovoid (1 time)
T-ring (1 time)
|
2020 A comparison of tandem ring and tandem ovoid treatment as a curative brachytherapy component for cervical cancer.
|
| 12 |
equivalent dose for 2-Gy fractions assuming alpha/beta of 10
(1 time)
|
Neoplasms
(1 time)
|
IGRT (1 time)
LRC (1 time)
MV (1 time)
|
2015 Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study.
|
| 13 |
equivalent dose in 2 Gy equivalents
(1 time)
|
Radiosurgery
(1 time)
|
ABP (1 time)
BPX (1 time)
SCV (1 time)
|
2020 Investigation of brachial plexus dose that exceeds RTOG constraints for apical lung tumors treated with four- or five-fraction stereotactic body radiation therapy.
|
| 14 |
equivalent dose normalized to 2 Gy-fractions
(1 time)
|
Neoplasms
(1 time)
|
4D FBCT (1 time)
CTV (1 time)
TCP (1 time)
|
2013 Dose escalation for locally advanced lung cancer using adaptive radiation therapy with simultaneous integrated volume-adapted boost.
|
| 15 |
equivalent dose to be administered in 2 Gy fractions
(1 time)
|
Radiotherapy
(1 time)
|
HA (1 time)
NC-VMAT (1 time)
OARs (1 time)
|
2023 Dose reduction of hippocampus using HyperArc planning in postoperative radiotherapy for primary brain tumors.
|
| 16 |
equivalent dose to the traditional 2Gy fractions
(1 time)
|
Radiology
(1 time)
|
BED (1 time)
CSC (1 time)
UMA (1 time)
|
2021 Theoretical derivation and clinical dose-response quantification of a unified multi-activation (UMA) model of cell survival from a logistic equation.
|
| 17 |
equivalent doses applied in fractions of 2 Gy
(1 time)
|
Neoplasms
(1 time)
|
CIR (1 time)
HNC (1 time)
OAR (1 time)
|
2019 Dose-Limiting Organs at Risk in Carbon Ion Re-Irradiation of Head and Neck Malignancies: An Individual Risk-Benefit Tradeoff.
|
| 18 |
equivalent to 2 Gy fractions of EBRT and BT
(1 time)
|
Neoplasms
(1 time)
|
EBRT (1 time)
HR-CTV (1 time)
IRCTV (1 time)
|
2011 Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
|
| 19 |
equivalent-dose conversions in 2 Gy
(1 time)
|
Neoplasms
(1 time)
|
BMs (1 time)
LQL (1 time)
M1-initial (1 time)
|
2022 Tumor Control Probability After Radiosurgery of Brain Metastases With and Without Retreatment.
|
A Search Service for Abbreviation / Long Form